Dimitra Papadopoulou

Biologist, Postdoc researcher, Assay development for drug discovery projects, in vivo experiments, writing for funding support and patent fillings

[George Kollias @KolliasLab]

A wonderful collaboration with the medicinal chemistry lab of Alexios Matralis and valued colleagues! First small molecule leads targeting #fibroblast activation driving chronic #inflammatorydisease and #fibrosis.

[George Kollias @KolliasLab]

Yes! It's public! Our lab's new work providing the first evidence of spatial spreading of intestinal inflammation via distinct fibroblast subsets. Amazing work .. all because of amazing Lida et al! @BSRC_Fleming @CrohnsColitisFn @ERC_Research https://t.co/ODPspDapn7

[Anastasios Liakos @AnastasiosLiak1]

Proud and extremely happy to see our recent work published  today @NAR_Open! Congratulations to all the (past and present) members of the #MFlab @BSRC_Fleming that contributed!
https://t.co/pOgXLk9DGu

[Dimitra Papadopoulou @DimPapad02]

An antipsychotic drug reduces arthritis in a fibroblast dependent model! Take a look on our work from @KolliasLab at @BSRC_Fleming published now in @JCI_insight. Thanks to our collaborators @Biomedcode @JesperOlsenLab

[JCI insight @JCI_insight]

Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis: https://t.co/MmO6Pr6Afa
@KolliasLab @BSRC_Fleming
#Therapeutics

[Dimitra Papadopoulou @DimPapad02]

Happy that our work at @KolliasLab in @BSRC_Fleming is now available as a preprint! @biorxivpreprint #arthritis #fibroblasts #DrugRepurposing

[bioRxiv @biorxivpreprint]

Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis. https://t.co/34SzC7zkB9 #bioRxiv

[Biomedical Sciences Research Center Al. Fleming @BSRC_Fleming]

The @KolliasLab @BSRC_Fleming is seeking motivated #postdocs to join a newly awarded #ERCAdG on “Contextual specification of #fibroblast driven causalities in #IBD and #fibrosis” @ERC_Research
Info: https://t.co/Z1Qhu1NDnw

[Nature Immunology @NatImmunol]

Kollias and colleagues examine FRC development during lymphoid organogenesis in gut PP: two separate mesenchymal cell lineages converge and form mosaic microenvironments that support immune cell activation and maintain intestinal homeostasis https://t.co/KCniKQSAH0